Lyetxi-b, a synthetic peptide derived from a spider venom, is highly active in triple-negative breast cancer cells and acts synergistically with cisplatin

HIGHLIGHTS

• who: A-MB- and collaborators from the Departamento Bioquu00edmica Imunologia, Instituto Ciu00eancias Biolu00f3gicas Universidade Federal Minas Gerais, Belo, Instituto Ciu00eancias Biolu00f3gicas Universidade Federal Minas Gerais, Belo Horizonte, Brazil have published the research: LyeTxI-b, a Synthetic Peptide Derived From a Spider Venom, Is Highly Active in Triple-Negative Breast Cancer Cells and Acts Synergistically With Cisplatin, in the Journal: (JOURNAL)
• what: The aim of this work was to evaluate the activity of LyeTx I-b and its combination with cisplatin against the breast cancer cell line MDA-MB-231.

SUMMARY

And . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or E-mail:

If you don't have an account, you can create one here.